Precigen Inc (NQ: PGEN )
1.650
+0.040
(+2.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
All News about Precigen Inc
![](https://public.newsdirect.com/617044025/BJlAx5US.png)
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 27, 2022
Via News Direct
Topics
Death
Exposures
Death
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 27, 2022
Via TheNewswire.com
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Monday's After-Market Session
December 19, 2022
Via Benzinga
Precigen Earnings Perspective: Return On Capital Employed
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/08/screenshot_2022-12-08_at_7.01.58_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/aapharma_8.png?width=1200&height=800&fit=crop)
Why Precigen Shares Are Gaining Today
July 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_6051.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2855.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15627.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/11/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/10/image-nvidia.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15370.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image-roblox.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8180.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/21/image-baker-hughes.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8141.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/image-nanoviricides.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/04/image34_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/20/image31_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/06/aapharma_5.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10022.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/06/image_3.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220328005813/en/538768/5/BES_Mark.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7009.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6909.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6805.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.